James Wooldridge
Chief Tech/Sci/R&D Officer at CHECKMATE PHARMACEUTICALS, INC.
James Wooldridge active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2019-09-30 | - |
Career history of James Wooldridge
Former positions of James Wooldridge
| Companies | Position | Start | End |
|---|---|---|---|
| SPYRE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2017-07-09 | 2019-10-09 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2005-12-31 | - |
Training of James Wooldridge
| Tulane University (Louisiana) | Doctorate Degree |
| William Jewell College | Undergraduate Degree |
Statistics
International
| United States | 6 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| SPYRE THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- James Wooldridge
- Experience
